Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
GRP.U
3751
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $444K | ﹤0.01% |
8,763
-28,622
| -77% | -$1.36M |
2022 Q4
10 quarters
|
|
3752
CALL
Travere Therapeutics
TVTX
$5.37B
| $444K | ﹤0.01% |
+30,000
| New | +$497K |
2025 Q2
0 quarters
|
|
3753
Krispy Kreme
DNUT
$498M
| $441K | ﹤0.01% |
151,547
-17,864
| -11% | -$62.4K |
2022 Q1
13 quarters
|
|
|
KGEI
3754
Kolibri Global Energy
KGEI
$224M
| $441K | ﹤0.01% |
64,363
+46,651
| +263% | +$321K |
2023 Q4
6 quarters
|
|
3755
Citizens Financial Services
CZFS
$387M
| $440K | ﹤0.01% |
7,500
+2,784
| +59% | +$160K |
2023 Q1
9 quarters
|
|
3756
Editas Medicine
EDIT
$404M
| $439K | ﹤0.01% |
199,530
+58,346
| +41% | +$95.5K |
2016 Q3
35 quarters
|
|
|
EFSI
3757
Eagle Financial Services Inc
EFSI
$247M
| $438K | ﹤0.01% |
+14,292
| New | +$442K |
2025 Q2
0 quarters
|
|
3758
Entravision Communication
EVC
$688M
| $437K | ﹤0.01% |
188,415
+43,083
| +30% | +$86.9K |
2016 Q1
37 quarters
|
|
3759
Rayonier Advanced Materials
RYAM
$486M
| $436K | ﹤0.01% |
113,248
+43,472
| +62% | +$183K |
2014 Q3
43 quarters
|
|
3760
Precigen
PGEN
$3.02B
| $435K | ﹤0.01% |
306,418
+126,583
| +70% | +$180K |
2022 Q1
13 quarters
|
|
3761
Limoneira
LMNR
$213M
| $435K | ﹤0.01% |
27,795
+11,138
| +67% | +$176K |
2022 Q3
11 quarters
|
|
|
TECX
3762
Tectonic Therapeutic
TECX
$434M
| $435K | ﹤0.01% |
21,891
+8,181
| +60% | +$166K |
2018 Q2
28 quarters
|
|
|
ZIMV
3763
DELISTED
ZimVie
ZIMV
| $434K | ﹤0.01% |
46,413
+18,439
| +66% | +$168K |
2022 Q1
13 quarters
|
|
3764
Abeona Therapeutics
ABEO
$292M
| $434K | ﹤0.01% |
76,401
-8,364
| -10% | -$47.6K |
2022 Q3
11 quarters
|
|
3765
Satellogic
SATL
$818M
| $434K | ﹤0.01% |
+119,875
| New | +$452K |
2025 Q2
0 quarters
|
|
3766
TFS Financial
TFSL
$4.69B
| $434K | ﹤0.01% |
33,503
+6,132
| +22% | +$79K |
2013 Q2
48 quarters
|
|
|
BRT
3767
BRT Apartments
BRT
$250M
| $434K | ﹤0.01% |
27,733
+16,278
| +142% | +$256K |
2017 Q4
30 quarters
|
|
|
KWY
3768
Kingsway Corp
KWY
$271M
| $434K | ﹤0.01% |
32,034
+18,253
| +132% | +$194K |
2023 Q1
9 quarters
|
|
3769
CALL
AMC Entertainment Holdings
AMC
$2.53B
| $430K | ﹤0.01% |
138,700
| – | – |
2024 Q2
4 quarters
|
|
3770
United States Natural Gas Fund
UNG
$472M
| $430K | ﹤0.01% |
28,118
+17,153
| +156% | +$296K |
2023 Q1
9 quarters
|
|
3771
Aura Biosciences
AURA
$644M
| $429K | ﹤0.01% |
68,551
+18,156
| +36% | +$106K |
2022 Q1
13 quarters
|
|
3772
Gencor Industries
GENC
$253M
| $428K | ﹤0.01% |
30,607
+9,146
| +43% | +$120K |
2023 Q4
6 quarters
|
|
3773
The Joint Corp
JYNT
$101M
| $428K | ﹤0.01% |
37,046
+15,083
| +69% | +$161K |
2019 Q1
25 quarters
|
|
3774
Rocket Pharmaceuticals
RCKT
$282M
| $427K | ﹤0.01% |
174,438
+7,556
| +5% | +$38.3K |
2019 Q1
25 quarters
|
|
3775
First Community Corp
FCCO
$309M
| $427K | ﹤0.01% |
17,528
+4,579
| +35% | +$105K |
2020 Q2
20 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.